Cohn Lillian B, Silva Israel T, Oliveira Thiago Y, Rosales Rafael A, Parrish Erica H, Learn Gerald H, Hahn Beatrice H, Czartoski Julie L, McElrath M Juliana, Lehmann Clara, Klein Florian, Caskey Marina, Walker Bruce D, Siliciano Janet D, Siliciano Robert F, Jankovic Mila, Nussenzweig Michel C
Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065, USA.
Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065, USA; National Institute of Science and Technology in Stem Cell and Cell Therapy and Center for Cell Based Therapy, Rua Catão Roxo, 2501, Ribeirão Preto CEP 14051-140, Brazil.
Cell. 2015 Jan 29;160(3):420-32. doi: 10.1016/j.cell.2015.01.020.
The barrier to curing HIV-1 is thought to reside primarily in CD4(+) T cells containing silent proviruses. To characterize these latently infected cells, we studied the integration profile of HIV-1 in viremic progressors, individuals receiving antiretroviral therapy, and viremic controllers. Clonally expanded T cells represented the majority of all integrations and increased during therapy. However, none of the 75 expanded T cell clones assayed contained intact virus. In contrast, the cells bearing single integration events decreased in frequency over time on therapy, and the surviving cells were enriched for HIV-1 integration in silent regions of the genome. Finally, there was a strong preference for integration into, or in close proximity to, Alu repeats, which were also enriched in local hotspots for integration. The data indicate that dividing clonally expanded T cells contain defective proviruses and that the replication-competent reservoir is primarily found in CD4(+) T cells that remain relatively quiescent.
治愈HIV-1的障碍被认为主要存在于含有沉默前病毒的CD4(+) T细胞中。为了表征这些潜伏感染的细胞,我们研究了HIV-1在病毒血症进展者、接受抗逆转录病毒治疗的个体以及病毒血症控制者中的整合情况。克隆扩增的T细胞占所有整合的大部分,且在治疗期间有所增加。然而,所检测的75个扩增T细胞克隆中均未包含完整病毒。相反,带有单个整合事件的细胞在治疗过程中频率随时间下降,存活细胞在基因组的沉默区域富集了HIV-1整合。最后,整合强烈偏好于Alu重复序列或其附近,这些区域在局部整合热点中也很富集。数据表明,克隆扩增的分裂T细胞含有缺陷前病毒,而具有复制能力的病毒库主要存在于相对静止的CD4(+) T细胞中。